fda to reconsider tirzepatide UPDATE [March 7, 2025]: OFA takes case appeals court as legal battle evolves Developments in diabetes management: What

Medicare will only cover GLP-1 receptor agonists for weight loss if there is a risk of heart disease, in addition to meeting the FDA weight requirements for prescription

"If you're an intermediate gym-goer stuck at a fat loss plateau..." 2000mg, taken 3045 minutes pre-workout

One common effect of HHcy is postural tachycardia syndrome (PoTS), which causes heart issues in people of all ages

Its being studied for more (addiction, mental health, Alzheimers) Prices are coming down (Zepbound is 20% less expensive than Wegovy) But, on the other hand: Medicare is legally prevented from covering GLP1s for obesity Only 16 states cover anti-obesity medications under Medicaid 50% or less commercial plans cover GLP1s for obesity, and those that do often have unreasonable hurdles Covered can still mean $500-1000 out of pocket every month

As you prepare for this next chapter, remember that you don't have to navigate the transition alone

Managing Weight Loss Treatment Alongside Bipolar Medication Successfully managing Mounjaro treatment whilst taking medication for bipolar disorder requires a coordinated, holistic approach to your healthcare